Eden's Platform Encapsulation Technology Patented in Philippines

Eden Research plc (EDEN) announces that the Intellectual Property Office of the Philippines has issued a Notice of Allowance for its platform encapsulation technology.

The patent covers the Company’s core technology, specifically "compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them."

The encapsulation system is owned outright by Eden and is already granted in Europe, New Zealand, Australia, China, Mexico, Singapore and South Africa. The benefit of having the patent formally granted is that it gives the security of full patent protection to existing and prospective licensees in the Philippines.

Clive Newitt, Managing Director of Eden comments: "We are delighted to announce this Notice of Allowance which further strengthens our intellectual property portfolio. The success of our application validates the uniqueness of our technology and its patentability. It also ensures that the commercial products being developed by our partners using our core technology are uniquely positioned in their markets."